Integration of proteomic and metabolomic analysis reveal distinct metabolic alterations of prostate cancer-associated fibroblasts compared to normal fibroblasts from patient's stroma samples.

Extracellular vesicles Human primary fibroblasts Mass spectrometry Metabolism Prostate cancer

Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
09 May 2024
Historique:
received: 27 11 2023
revised: 25 04 2024
accepted: 06 05 2024
medline: 12 5 2024
pubmed: 12 5 2024
entrez: 11 5 2024
Statut: aheadofprint

Résumé

The prostate gland is a complex and heterogeneous organ composed of epithelium and stroma. Whilst many studies into prostate cancer focus on epithelium, the stroma is known to play a key role in disease with the emergence of a cancer-associated fibroblasts (CAF) phenotype associated upon disease progression. In this work, we studied the metabolic rewiring of stromal fibroblasts following differentiation to a cancer-associated, myofibroblast-like, phenotype. We determined that CAFs were metabolically more active compared to normal fibroblasts. This corresponded with a heightened lipogenic metabolism, as both reservoir species and building block compounds. Interestingly, lipid metabolism affects mitochondria functioning yet the mechanisms of lipid-mediated functions are unclear. Data showing oxidised fatty acids and glutathione system are elevated in CAFs, compared to normal fibroblasts, strengthens the hypothesis that increased metabolic activity is related to mitochondrial activity. This manuscript describes mechanisms responsible for the altered metabolic flux and shows that prostate cancer-derived extracellular vesicles can increase basal respiration in normal fibroblasts, mirroring that of the disease-like phenotype. This indicates that extracellular vesicles derived from prostate cancer cells may drive an altered oxygen-dependent metabolism associated to mitochondria in CAFs.

Identifiants

pubmed: 38734319
pii: S0925-4439(24)00218-7
doi: 10.1016/j.bbadis.2024.167229
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167229

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Guillermo Bordanaba-Florit (G)

Exosomes Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Derio, Spain. Electronic address: gbordanaba@cicbiogune.es.

Félix Royo (F)

Exosomes Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), 28029 Madrid, Spain.

Oihane E Albóniga (OE)

Metabolomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Derio, Spain.

Aled Clayton (A)

Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.

Juan Manuel Falcón-Pérez (JM)

Exosomes Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), 28029 Madrid, Spain; Metabolomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Derio, Spain.

Jason Webber (J)

Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, UK. Electronic address: j.p.webber@swansea.ac.uk.

Classifications MeSH